HeartSciences (HSCSW) FCF Margin (2021 - 2025)

HeartSciences (HSCSW) reported FCF Margin of 96497.15% for Q4 2025, up 6.14% quarter-over-quarter from 102808.79% in Q3 2025.

HeartSciences (HSCSW) FCF Margin (2021 - 2025) Analysis & Trends

HeartSciences has reported FCF Margin for 5 years, with the latest figure at 96497.15% in Q4 2025.

For the quarter ending Q4 2025, FCF Margin changed N/A year-over-year to 96497.15%; the trailing twelve-month figure through Jan 2026 stood at 84569.42% (down 4452686.0% YoY), and the FY2025 full-year result was 170486.23%, down 13750429.0% from the prior year.
FCF Margin for Q4 2025 stood at 96497.15%, up from 102808.79% in the prior quarter.
The five-year high for FCF Margin was 9587.0% in Q3 2021, with the low at 102808.79% in Q3 2025.
Historically, FCF Margin has averaged 45853.2% across 5 years, with a median of 35916.03% in 2025.
Annual changes were most pronounced in 2022 — FCF Margin sank 4725534 bps — and 2024, when it surged 3813463 bps.
HeartSciences' FCF Margin stood at 9587.0% in 2021, then sank by 493 bps to 56842.34% in 2022, then surged by 55 bps to 25388.18% in 2023, then surged by 43 bps to 14352.14% in 2024, then slumped by 572 bps to 96497.15% in 2025.
The last three FCF Margin figures came in at 96497.15% (Q4 2025), 102808.79% (Q3 2025), and 36566.44% (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	8.20%
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	6.89%
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	25.51%
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	3.29%
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	-1.28%
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	3.98%
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	6.68%
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	37.67%
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	15.44%
10	HeartSciences	-	-	-	-

Download Data